Montral Syrup is a combination medicine containing levocetirizine dihydrochloride (2.5mg/5ml) and montelukast sodium (4mg/5ml). It is indicated for the treatment of seasonal allergic rhinitis (SAR), perennial allergic rhinitis (PAR), and chronic spontaneous urticaria (CSU). The syrup is designed to provide rapid and sustained relief from allergic symptoms, including nasal congestion, sneezing, runny nose, itchy and watery eyes, and itching of the skin. The levocetirizine component exhibits potent antihistaminic activity, whereas the montelukast component demonstrates potent cysteinyl leukotriene (CysLT1) receptor antagonist activity. The combination of these two active ingredients offers a unique therapeutic profile, providing a broad-spectrum approach to managing allergic reactions. As a syrup, Montral is easy to administer and can be used in children and adults alike. Its once-daily dosing regimen simplifies treatment adherence, making it an attractive option for patients seeking convenient and effective relief from allergic symptoms.